Top Five Articles on 360Dx Last Week: Siemens Healthineers Layoffs and Atellica Focus; and More
Last week, readers were most interested in a story about changes at Siemens Healthineers as it plans to shut down some of its legacy instruments.
QuidelOrtho COVID-19 Serology Tests Gain FDA Marketing Authorization
The tests are intended for prescription use for the detection of IgG antibodies to SARS-CoV-2 in human serum and plasma samples.
QuidelOrtho Q1 Revenues Drop 16 Percent
The firm's non-respiratory revenue was up 5 percent due to the Labs business, while respiratory revenue was down 72 percent.
Top Five Articles on 360Dx Last Week: FDA Clearances in March; Oncocyte Layoffs; and More
Last week, readers were most interested in a story about 510(k) clearances issued by the FDA last month.
QuidelOrtho Preliminary Q1 Revenues Beat Estimates
The firm said Thursday that it expects revenues between $840 million and $850 million for the quarter ended April 2 compared to Wall Street's average prediction of $747 million.
Feb 16, 2023